Navigation Links
IPRO Wins Federal Contract to Support Hospice Oversight
Date:10/19/2009

LAKE SUCCESS, N.Y., Oct. 19 /PRNewswire-USNewswire/ -- IPRO has been awarded special federal funding to support the assessment and improvement of Medicare-funded hospice services. As the Medicare Quality Improvement Organization (QIO) for the state of New York, IPRO collaborates with providers on performance improvement in a variety of settings. QIOs operate in all fifty states in the U.S. under contract with the federal Centers for Medicare & Medicaid Services (CMS).

(Logo: http://www.newscom.com/cgi-bin/prnh/20080725/DC28791LOGO)

Despite well-documented benefits of palliative-oriented end-of-life care for certain Medicare beneficiaries, timely referral to certified hospice programs is often suboptimal and not always available to members of racial and ethnic minority groups. Under the CMS-funded special study, IPRO will partner with eight New York-based, Medicare-certified hospice programs to promote timely referrals, to support the integration of hospice into the overall health system and to test first-generation performance measures.

"IPRO has selected a diverse group of programs to participate in this special project so that the measures and data collection instruments are tested in the full range of hospice program environments and patient populations," says Clare B. Bradley, MD, MPH, Chief Medical Officer, IPRO. "With spending expected to exceed $10 billion in FY 2009, there is an urgent need to assure the quality of healthcare services provided by hospices."

Working with IPRO, hospice programs will collect and submit a standard set of patient-level data elements for a one-year period in order to test previously developed quality measures. IPRO will perform statistical analyses of the properties of these measures, including identifying any racial or ethnic differences in performance, and conduct focus groups of family members, hospice staff members, hospice referral sources and Medicare beneficiaries to evaluate the usefulness of the measures to each group.

With the assistance of the School of Public Health of the State University of New York at Albany, IPRO will also conduct a comprehensive literature review of end-of-life care, with a special emphasis on studies concerning cultural beliefs and differences in attitudes about death and dying. Findings from the literature review, focus groups and quality measures analysis will be used to formulate interventions to address identified disparities.

About IPRO

IPRO is a national organization providing a full spectrum of healthcare assessment and improvement services that foster more efficient use of resources and enhance healthcare quality to achieve better patient outcomes. Founded in 1984, IPRO is highly regarded for the independence of its approach, the depth of its knowledge and experience, and the integrity of its programs. IPRO holds contracts with federal, state and local government agencies, as well as private sector clients, operating best-of-class programs in more than 33 states and the District of Columbia. A national nonprofit organization, IPRO is headquartered in Lake Success, New York and is a 501(c)(3) corporation.

SOURCE IPRO


'/>"/>
SOURCE IPRO
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Homecare Recipients and Providers to Rally against Cuts in IHSS Program; Hearing on Lawsuit in Oakland Federal Court Monday
2. Department of Public Welfare Earns Federal Recognition for Programs and Services for Children
3. NeuroAIDS is Target of Federal Grant to Childrens Hospital
4. Feinstein Investigators Receive Federal GO Grant to Study the Genetics of Schizophrenia
5. BayCare Behavioral Health and Homeless Emergency Project Receive Federal Grant to Help Break the Cycle of Homelessness
6. National Changing Diabetes Program Members Issue Statement Regarding New Federal Medical Research Grants
7. Federal stimulus funding channels more than $40 million to Fred Hutchinson Cancer Research Center
8. Deputy Secretary Gould Talks Strategies for Federal Performance
9. $16 Million in Federal Stimulus Funding Establishes Seattle as a Hub of Comparative-Effectiveness Research In Cancer
10. Federal Stimulus Funding Channels More Than $40 Million to Fred Hutchinson Cancer Research Center
11. Einstein receives $2.1 million federal grant to support Hispanic Center of Excellence
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/15/2017)... ... August 15, 2017 , ... ... at his Inauguration that WesternU will move forward in bold new directions while ... WesternU combined Wilson’s Inauguration ceremony with Convocation, the traditional opening of the academic ...
(Date:8/15/2017)... ... August 15, 2017 , ... Horizon Goodwill is honored to ... are overwhelmed with gratitude for the very generous donation from BB&T. Our mission ... both get a job and keep it. This donation will go a long ...
(Date:8/15/2017)... ... August 15, 2017 , ... IsoComforter, Inc., one of the ... innovative new 10x10 bladder pad ( isocomforter.com/product/10x10-sterile-pad/ ). The newly designed bladder pad ... enables the patient to enjoy the benefits of cold therapy while resting, sitting, ...
(Date:8/15/2017)... ... August 15, 2017 , ... Harris Communications, Inc. is bringing its ... Twin Cities Living Well with Hearing Loss Conference, 9:30-2 p.m. Saturday, Nov. 18 at ... for Harris Communications at tables 8 and 9. , During the conference, attendees can ...
(Date:8/15/2017)... Glan Allen,VA (PRWEB) , ... August 15, 2017 ... ... of CoolSculpting to their leading selection of services. FDA-cleared CoolSculpting is the world’s ... and counting. Without surgery or downtime, CoolSculpting can reduce fat cells in almost ...
Breaking Medicine News(10 mins):
(Date:7/27/2017)... Services, Inc. (NYSE: WST ) today announced ... financial guidance for the full-year 2017. ... Reported net sales of $397.6 million, a record high, ... constant currency (organic) grew by 3.9%. ... in the prior-year quarter. Second-quarter 2017 adjusted diluted EPS ...
(Date:7/26/2017)... July 26, 2017 Sancilio Pharmaceuticals Company, Inc. ... clinical trial evaluating Altemia TM , an oral therapy ... Sickle Cell Disease (SCD). The SCOT Trial, is a ... and safety of Altemia TM in pediatric patients ... US IND 125274. ...
(Date:7/25/2017)... -- Debbie,s Dream Foundation: Curing Stomach Cancer (DDF) is excited to host its 3 ... Bonaventure Resort & Spa in Weston, Florida beginning at ... Luncheon Committee Co-chair ... Luncheon Committee Co-chair Sabrina Kurzman. ... Aura Morales-Guzman, Angela Perez, DDF Board Member John ...
Breaking Medicine Technology: